Wednesday, December 18, 2024
Home Tags Innv

Tag: innv

Steven Boyd, Armistice Capital, Biotech Stock Review
Biotech News

Armistice Capital Voting on AYTU (AYTU) and Innovus (INNV) Merger.

Editor / Curator -
biotech stock review
Biotech News

Innovus (INNV) Gains 75% in Past Week.

Editor / Curator -
Biotech News

Innovus Pharma Reports 2Q 2019 of $6.8 million, a 27.7% Increase...

Editor / Curator -
Biotech News

Innovus (INNV) New E-Commerce Store on Track for $3 million in...

Editor / Curator -
DIABASENS
All News

Diabasens® to Launch in Europe. Innovus (INNV).

Editor / Curator -
Biotech News

Innovus (INNV) in Silicon Review Interview.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Transcript.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

Editor / Curator -
biotech stock review, innovus
All News

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Editor / Curator -
biotech stock review, zestra
Biotech News

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for...

Editor / Curator -
12Page 1 of 2

Latest article

Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.

All News Editor / Curator -
119% Gain Post Split

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.